ReviewClinical and molecular hepatology2026

Risk assessment in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-related liver disease: current approaches and future directions.

Huapeng Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.